Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond
Authors
Keywords
-
Journal
RADIOTHERAPY AND ONCOLOGY
Volume 166, Issue -, Pages 1-7
Publisher
Elsevier BV
Online
2021-11-11
DOI
10.1016/j.radonc.2021.11.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of PSA bounce in prostate cancer following definitive radiation therapy: a systematic review and meta-analysis
- (2021) Fumihiko Urabe et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A bicentric retrospective analysis of clinical utility of 18F-fluciclovine PET in biochemically recurrent prostate cancer following primary radiation therapy: is it helpful in patients with a PSA rise less than the Phoenix criteria?
- (2021) Ali Salavati et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single Center Study
- (2020) Ida Sonni et al. JOURNAL OF NUCLEAR MEDICINE
- Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
- (2020) Michael S Hofman et al. LANCET
- False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial
- (2020) Wolfgang P. Fendler et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?
- (2020) Maha Hussain et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients
- (2020) Rebecca Levin-Epstein et al. RADIOTHERAPY AND ONCOLOGY
- Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy of Clinically Localized Prostate Cancer
- (2019) Michael J. Zelefsky et al. JOURNAL OF UROLOGY
- Prostate-specific Antigen Bounce After Stereotactic Body Radiotherapy for Prostate Cancer: A Pooled Analysis of Four Prospective Trials
- (2019) S. Roy et al. CLINICAL ONCOLOGY
- Multi-institutional Analysis of Prostate-Specific Antigen Kinetics Following Stereotactic Body Radiotherapy (SBRT)
- (2019) Naomi Y. Jiang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The use of 68Ga-PET/CT PSMA to determine patterns of disease for biochemically recurrent prostate cancer following primary radiotherapy
- (2019) Sheliyan Raveenthiran et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Prostate-Specific Antigen (PSA) Bounce After Dose-Escalated External Beam Radiation Therapy Is an Independent Predictor of PSA Recurrence, Metastasis, and Survival in Prostate Adenocarcinoma Patients
- (2018) Paul B. Romesser et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survival
- (2017) Carla Freiberger et al. Radiation Oncology
- Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir
- (2014) Mekhail Anwar et al. Radiation Oncology
- Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
- (2014) Charles C. Vu et al. Frontiers in Oncology
- Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
- (2013) Leonard N Chen et al. Radiation Oncology
- Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
- (2013) Alan J Katz et al. Radiation Oncology
- Prostate Specific Antigen Bounce Is Related to Overall Survival in Prostate Brachytherapy
- (2011) Karel A. Hinnen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PSA Bounce and Biochemical Failure After Brachytherapy for Prostate Cancer: A Study of 820 Patients With a Minimum of 3 Years of Follow-Up
- (2010) Murat Caloglu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival
- (2009) Juanita M. Crook et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now